Next 20 Records New Search

Your search found 81 records, sorted by year and then date of acquisition.

1. Comparative Effectiveness of Extended-Release Naltrexone Versus Buprenorphine-Naloxone for Opioid Relapse Prevention (X:BOT): A Multicentre, Open-Label, Randomised Controlled Trial. doc type doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bachrach, Ken ; Bailey, Genie L. ; Bhatt, Snehal ; Farkas, Sarah ; Fishman, Marc J. ; Gauthier, Phoebe ; Hodgkins, Candace C. ; King, Jacquie ; Lindblad, Robert ; Liu, David S. ; Matthews, Abigail G. ; May, Jeanine ; Peavy, K. Michelle ; Ross, Stephen ; Salazar, Dagmar ; Schkolnik, Paul ; Shmueli-Blumberg, Dikla ; Stablein, Don ; Subramaniam, Geetha A. ; Rotrosen, John
 The Lancet 2017 (in press). [doi: 10.1016/S0140-6736(17)32812-X].
 
2. Prescription Opioid Registry Protocol in an Integrated Health System. doc type
  Ray, G. Thomas ; Bahorik, Amber L. ; VanVeldhuisen, Paul C. ; Weisner, Constance M. ; Rubinstein, Andrea L. ; Campbell, Cynthia I.
 American Journal of Managed Care 2017;23(5):e146-e155..
 
3. High Mortality Among Patients with Opioid Use Disorder in a Large Healthcare System. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Zhu, Yuhui ; Liang, Di ; Huang, David
 Journal of Addiction Medicine 2017;11(4):315-319. [doi: 10.1097/ADM.0000000000000312].
 
4. The Prescription Opioid Addiction Treatment Study: What Have We Learned. doc type
  Weiss, Roger D. ; Rao, Vinod
 Drug and Alcohol Dependence 2017;173:S48-S54. [doi: 10.1016/j.drugalcdep.2016.12.001].
 
5. Chronic Pain Among Patients with Opioid Use Disorder: Results from Electronic Health Records Data. doc type
  Hser, Yih-Ing ; Mooney, Larissa J. ; Saxon, Andrew J. ; Miotto, Karen ; Bell, Douglas S. ; Huang, David
 Journal of Substance Abuse Treatment 2017;77:26–30. [doi: 10.1016/j.jsat.2017.03.006].
 
6. Volatility and Change in Chronic Pain Severity Predict Outcomes of Treatment for Prescription Opioid Addiction. doc type
  Worley, Matthew J. ; Heinzerling, Keith G. ; Shoptaw, Steven ; Ling, Walter
 Addiction 2017;112(7):1202-1209. [doi: 10.1111/add.13782].
 
7. Distinctive Trajectories of Opioid Use Over an Extended Follow-Up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone. doc type
  Hser, Yih-Ing ; Huang, David ; Saxon, Andrew J. ; Woody, George ; Moskowitz, Andrew L. ; Matthews, Abigail G. ; Ling, Walter
 Journal of Addiction Medicine 2017;11(1):63-69. [doi: 10.1097/ADM.0000000000000274].
 
8. Causes of Death and Expected Years of Life Lost Among Treated Opioid-Dependent Individuals in the United States and Taiwan. doc type
  Chang, Kun-Chia ; Wang, Jung-Der ; Saxon, Andrew J. ; Matthews, Abigail G. ; Woody, George E. ; Hser, Yih-Ing
 International Journal of Drug Policy 2017;45:1-6. [doi: 10.1016/j.drugpo.2016.12.003].
 
9. Identifying Substance Misuse in Primary Care: TAPS Tool Compared to the WHO ASSIST. doc type
  Schwartz, Robert P. ; McNeely, Jennifer ; Wu, Li-Tzy ; Sharma, Gaurav ; Wahle, Aimee ; Cushing, Carol ; Nordeck, Courtney ; Sharma, Anjalee ; O'Grady, Kevin E. ; Gryczynski, Jan ; Mitchell, Shannon G. ; Ali, Robert L. ; Marsden, John ; Subramaniam, Geetha A.
 Journal of Substance Abuse Treatment 2017;76:69–76. [doi: 10.1016/j.jsat.2017.01.013].
 
10. An Item Bank for Abuse of Prescription Pain Medication from the Patient-Reported Outcomes Measurement Information System (PROMIS). doc type
  Pilkonis, Paul A. ; Yu, Lan ; Dodds, Nathan E. ; Johnston, Kelly L. ; Lawrence, Suzanne M. ; Hilton, Thomas F. ; Daley, Dennis C. ; Patkar, Ashwin A. ; McCarty, Dennis
 Pain Medicine 2017;18(8):1516-1527. [doi: 10.1093/pm/pnw233].
 
11. CSAT/CTN Webinar: NIDA CTN Initiatives and Primary Care Opioid Use Disorders Treatment Trial Briefing. doc type
  Johnson, Kimberly ; Tai, Betty ; Bradley, Katharine
 Webinar presented October 19, 2016.
 
12. Ethical and Clinical Safety Considerations in the Design of an Effectiveness Trial: A Comparison of Buprenorphine Versus Naltrexone Treatment for Opioid Dependence. doc type
  Nunes, Edward V. ; Lee, Joshua D. ; Sisti, Dominic ; Segal, Andrea ; Caplan, Arthur ; Fishman, Marc J. ; Bailey, Genie L. ; Brigham, Gregory S. ; Novo, Patricia ; Farkas, Sarah ; Rotrosen, John
 Contemporary Clinical Trials 2016;51:34-43. [doi: 10.1016/j.cct.2016.09.006].
 
13. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. doc type
  McNeely, Jennifer ; Wu, Li-Tzy ; Subramaniam, Geetha A. ; Sharma, Gaurav ; Cathers, Lauretta A. ; Svikis, Dace S. ; Sleiter, Luke ; Russell, Linnea ; Nordeck, Courtney ; Sharma, Anjalee ; O'Grady, Kevin E. ; Bouk, Leah B. ; Cushing, Carol ; King, Jacqueline ; Wahle, Aimee ; Schwartz, Robert P.
 Annals of Internal Medicine 2016;165(10):690-699. [doi: 10.7326/M16-0317].
 
14. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale. doc type
  Lee, Joshua D. ; Nunes, Edward V. ; Novo, Patricia ; Bailey, Genie L. ; Brigham, Gregory S. ; Cohen, Allan J. ; Fishman, Marc J. ; Ling, Walter ; Lindblad, Robert ; Shmueli-Blumberg, Dikla ; Stablein, Don ; May, Jeanine ; Salazar, Dagmar ; Liu, David S. ; Rotrosen, John
 Contemporary Clinical Trials 2016;50:253-264. [doi: 10.1016/j.cct.2016.08.004].
 
15. Hair Analysis and Its Concordance with Self-Report for Drug Users Presenting in Emergency Departments. doc type
  Sharma, Gaurav ; Oden, Neal L. ; VanVeldhuisen, Paul C. ; Bogenschutz, Michael P.
 Drug and Alcohol Dependence 2016;167:149-155. [doi: 10.1016/j.drugalcdep.2016.08.007].
 
16. Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool. doc type
  Wu, Li-Tzy ; McNeely, Jennifer ; Subramaniam, Geetha A. ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Schwartz, Robert P.
 Contemporary Clinical Trials 2016;50:90-97. [doi: 10.1016/j.cct.2016.07.013].
 
17. Changes in Quality of Life in Cocaine-Dependent Participants Provided Treatment with Buprenorphine+Naloxone Combined with Extended Release Naltrexone. doc type
  Shmueli-Blumberg, Dikla ; Carrizales, Fermin A. ; Kazanis, William H. ; Hillhouse, Maureen ; Matthews, Abigail ; Potter, Jennifer Sharpe
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
18. Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Matthews, Abigail G. ; Hillhouse, Maureen ; Thomas, Christie ; Ling, Walter ; Shmueli-Blumberg, Dikla
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Palm Springs, CA, June 11-16, 2016.
 
19. Longitudinal Association Between Pain Severity and Subsequent Opioid Use in Prescription Opioid Dependent Patients with Chronic Pain. doc type
  Griffin, Margaret L. ; McDermott, Katherine A. ; McHugh, R. Kathryn ; Fitzmaurice, Garrett M. ; Jamison, Robert N. ; Weiss, Roger D.
 Drug and Alcohol Dependence 2016;163(1):216-221. [doi: 10.1016/j.drugalcdep.2016.04.023].
 
20. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 

  Next 20 Records New Search